Cargando…
Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study
OBJECTIVE: The aim of this exploratory study was to investigate the development of low‐grade inflammation during ageing and its relationship with frailty. METHODS: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5‐year intervals over a period of 20 years from 144...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826353/ https://www.ncbi.nlm.nih.gov/pubmed/35154709 http://dx.doi.org/10.1002/cti2.1374 |
_version_ | 1784647413951102976 |
---|---|
author | Samson, Leonard Daniël Buisman, Anne‐Marie Ferreira, José A Picavet, H Susan J Verschuren, W M Monique Boots, Annemieke MH Engelfriet, Peter |
author_facet | Samson, Leonard Daniël Buisman, Anne‐Marie Ferreira, José A Picavet, H Susan J Verschuren, W M Monique Boots, Annemieke MH Engelfriet, Peter |
author_sort | Samson, Leonard Daniël |
collection | PubMed |
description | OBJECTIVE: The aim of this exploratory study was to investigate the development of low‐grade inflammation during ageing and its relationship with frailty. METHODS: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5‐year intervals over a period of 20 years from 144 individuals aged 65–75 years at the study endpoint, were related to the degree of frailty later in life. RESULTS: IFN‐γ‐related markers and platelet activation markers were found to change in synchrony. Chronically elevated levels of IL‐6 pathway markers, such as CRP and sIL‐6R, were associated with more frailty, poorer lung function and reduced physical strength. Being overweight was a possible driver of these associations. More and stronger associations were detected in women, such as a relation between increasing sCD14 levels and frailty, indicating a possible role for monocyte overactivation. Multivariate prediction of frailty confirmed the main results, but predictive accuracy was low. CONCLUSION: In summary, we documented temporal changes in and between inflammatory markers in an ageing population over a period of 20 years, and related these to clinically relevant health outcomes. |
format | Online Article Text |
id | pubmed-8826353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88263532022-02-11 Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study Samson, Leonard Daniël Buisman, Anne‐Marie Ferreira, José A Picavet, H Susan J Verschuren, W M Monique Boots, Annemieke MH Engelfriet, Peter Clin Transl Immunology Original Article OBJECTIVE: The aim of this exploratory study was to investigate the development of low‐grade inflammation during ageing and its relationship with frailty. METHODS: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5‐year intervals over a period of 20 years from 144 individuals aged 65–75 years at the study endpoint, were related to the degree of frailty later in life. RESULTS: IFN‐γ‐related markers and platelet activation markers were found to change in synchrony. Chronically elevated levels of IL‐6 pathway markers, such as CRP and sIL‐6R, were associated with more frailty, poorer lung function and reduced physical strength. Being overweight was a possible driver of these associations. More and stronger associations were detected in women, such as a relation between increasing sCD14 levels and frailty, indicating a possible role for monocyte overactivation. Multivariate prediction of frailty confirmed the main results, but predictive accuracy was low. CONCLUSION: In summary, we documented temporal changes in and between inflammatory markers in an ageing population over a period of 20 years, and related these to clinically relevant health outcomes. John Wiley and Sons Inc. 2022-02-09 /pmc/articles/PMC8826353/ /pubmed/35154709 http://dx.doi.org/10.1002/cti2.1374 Text en © 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Article Samson, Leonard Daniël Buisman, Anne‐Marie Ferreira, José A Picavet, H Susan J Verschuren, W M Monique Boots, Annemieke MH Engelfriet, Peter Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
title | Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
title_full | Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
title_fullStr | Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
title_full_unstemmed | Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
title_short | Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
title_sort | inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826353/ https://www.ncbi.nlm.nih.gov/pubmed/35154709 http://dx.doi.org/10.1002/cti2.1374 |
work_keys_str_mv | AT samsonleonarddaniel inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy AT buismanannemarie inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy AT ferreirajosea inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy AT picavethsusanj inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy AT verschurenwmmonique inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy AT bootsannemiekemh inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy AT engelfrietpeter inflammatorymarkertrajectoriesassociatedwithfrailtyandageingina20yearlongitudinalstudy |